Latest News Release

Oncolytics Biotech Inc. to Present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference

Oncolytics Biotech Inc.’s Research Collaborators Present Data on the Enhancement of the Cytotoxicity of Cancer Drugs by REOLYSIN®

Oncolytics Biotech Inc. to Present at the Wall Street Analyst Forum

Oncolytics Biotech Inc. Announces 2004 Second Quarter Results

Oncolytics Biotech Inc. Market Update

Oncolytics Biotech Starts Patient Treatment in UK Phase I Cancer Trial Investigating Systemic Delivery of REOLYSIN®

Oncolytics Biotech Inc. Announces 2004 First Quarter Results

Oncolytics Biotech Inc. Closes Private Placement


Year

Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More

Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More

View all news articles

Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More

Exploring REOLYSIN<sup>®</sup>’s Objective Response Rate in Females with Colorectal Cancer thumbail
View all blog posts

LATEST TWEETS

Follow us on Twitter